C6K0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Avalo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 15.64 EUR -3.93% Market Closed

Market Cap: €283.6m

	Avalo Therapeutics Inc F:C6K0	US
	Bayer AG OTC:BAYZF	DE
R	Rockfire Resources PLC F:P2P	UK
J	J Sainsbury PLC SWB:SUY1	UK
	Ozon Holdings PLC MOEX:OZON	CY
L	Leoni AG XBER:LEO	DE

Profitability Summary

Avalo Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

105%

Gross Margin is Increasing

86% > 100%

Negative Operating Margin

-123 602%

Negative 3Y Average Operating Margin

-18 716%

Declining Operating Margin

-122% > -123 602%

Negative Net Margin

-132 642%

Negative 3Y Average Net Margin

-21 305%

Declining Net Margin

-146% > -132 642%

Negative Free Cash Flow Margin

-87 217%

Negative 3Y Average Free Cash Flow Margin

-14 686%

Declining Free Cash Flow Margin

-115% > -87 217%

Negative ROE

-72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-281%

Declining ROIC

-115% > -428%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.